Vocan
is a biotechnology company that researches and develops depression and anxiety therapy treatments for patients... Read moreVocan
is a biotechnology company that researches and develops depression and anxiety therapy treatments for patients... Read more
Chairman & CEO
Robert E.W. Hancock
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Jul 11, 2023
FinanzNachrichten
Vocan : Core One Labs Inc.: Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
Jul 07, 2023
FinanzNachrichten
Vocan : Core One Labs Inc.: Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method
Aug 16, 2022
FinanzNachrichten
Vocan : Core One Labs Inc.: Core One Labs' Vocan Successfully Converts Psilocin Precursor into Psilocybin
Mar 15, 2022
Life Care News
Vocan : Core One's Vocan Biotechnologies and Awakened Biosciences
Feb 09, 2022
MarketScreener
Vocan : Core One Labs' Successful Patent Application Filing for Protection of its Biosynthetic Production System for Psilocybin Marks a Significant Milestone for the Progression of Psychedelic Health Care
Jun 14, 2021
Equity Guru
Vocan : Core One Labs (COOL.C) subsidiary approaching finalization of patent application, stock up 12%
Apr 26, 2021
Equity Guru
Vocan : Core One Labs (COOL.C) takes their artificial psilocybin research to UBC
Apr 21, 2021
CFN Media Group
Vocan : Core One Labs' Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
Mar 04, 2021
Accesswire
Press Release: Vocan : Core One Labs' Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvo to License Bioynthesized Psilocybin in Brazil
Jan 25, 2021
Equity Guru
Vocan : Core One Labs (COOL.C) subsidiary Vocan Biotechnologies is ready for 2021 with a near triple, and new recombinant psilocybin tech